New horizons in the pathogenesis, assessment and management of movement disorders

  1. Lookup NU author(s)
  2. Dr Gordon Duncan
  3. Dr Alison Yarnall
  4. Dr Sarah Marrinan
  5. Professor David Burn
Author(s)Duncan GW, Yarnall AJ, Marrinan S, Burn DJ
Publication type Review
JournalAge and Ageing
Year2013
Volume42
Issue1
Pages2-10
ISSN (print)0002-0729
ISSN (electronic)1468-2834
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
In this review, we shall outline recent advances in our understanding of the movement disorders which geriatricians encounter in their clinical practice. Many of these diseases are no longer simply considered disorders of movement: carefully conducted longitudinal studies have shown that concomitant cognitive dysfunction, neuropsychiatric disturbance and behavioural issues are frequent and exert a heavy burden on the individual and their carers. Great progress has been made in understanding the molecular and cellular processes that drive the pathological changes in these conditions, as have advances in neuroimaging and preclinical drug discovery programmes. Unfortunately, this is yet to translate into disease-modifying therapies for these progressive disorders. Advances have been also made in non-pharmacological interventions such as tailored physiotherapy and speech therapy programmes. The important contribution of palliative care has been recognised and increasingly incorporated into the multidisciplinary approach. The UK is at the forefront of research into these conditions and geriatricians are well placed to contribute to research through recruiting patients to observational studies or therapeutic trials, particularly with the support of agencies such as the National Institute for Health Research-Dementias & Neurodegenerative Diseases Research Network (NIHR-DeNDRoN).
URLhttp://dx.doi.org/10.1093/ageing/afs103
DOI10.1093/ageing/afs103
PubMed id22908205
Actions    Link to this publication
Share